However, cancer cells, especially of the breast, prostate, colon, ovary, endometrium, and thyroid origin, express very high levels of FASN and this up-regulation is under the control of aberrant MAPK and PI-3K-Akt signaling [2], [7]–[9]. This evidence concerns the gene FASN and cancer.